NCT00461344View on ClinicalTrials.gov

Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

August 31, 2007

Conditions

Ductal Carcinoma

Interventions

DRUG

Docetaxel

DRUG

Doxorubicin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY